CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 134 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,731,000 | -35.8% | 338,000 | -10.6% | 0.02% | -32.4% |
| Q2 2019 | $2,695,000 | -79.3% | 378,000 | -61.3% | 0.03% | -79.5% |
| Q1 2019 | $12,988,000 | +68.7% | 978,000 | 0.0% | 0.17% | +40.7% |
| Q4 2018 | $7,697,000 | -27.5% | 978,000 | +2.1% | 0.12% | -16.3% |
| Q3 2018 | $10,615,000 | +68.3% | 958,000 | +103.8% | 0.14% | +41.0% |
| Q2 2018 | $6,308,000 | +98.2% | 470,000 | +91.8% | 0.10% | +85.2% |
| Q1 2018 | $3,183,000 | +156.3% | 245,000 | +81.5% | 0.05% | +157.1% |
| Q4 2017 | $1,242,000 | – | 135,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
| Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
| Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
| Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
| Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
| DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
| Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
| Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
| NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
| Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |